﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>16</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2026</Year>
        <Month>01</Month>
        <DAY>04</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Pharmacists in modern primary care and management of diseases: an evidence-based perspective on emerging technologies</ArticleTitle>
    <FirstPage>33050</FirstPage>
    <LastPage>33050</LastPage>
    <ELocationID EIdType="doi">10.34172/bi.33050</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Jaleh</FirstName>
        <LastName>Barar</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0105-919X</Identifier>
      </Author>
      <Author>
        <FirstName>Yadollah</FirstName>
        <LastName>Omidi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-0067-2475</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>EDITORIAL</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bi.33050</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>10</Month>
        <Day>24</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <Abstract>Modern healthcare demands warrant the reconceptualization of pharmaceutical practitioners as primary caregivers capable of addressing contemporary medical challenges. Their specialized knowledge in molecular therapeutics, computational medicine tools, and physiological surveillance technologies uniquely qualifies them to oversee complicated treatment protocols for cutting-edge interventions, including genomic modifications and targeted biological agents. Historical success in managing long-term metabolic and cardiovascular conditions establishes credibility for supervising precision medicine applications. Digital innovations (e.g., remote consultation systems, algorithmic forecasting, and distributed ledger prescription tracking) enhance their capacity to coordinate fragmented services while responding to infectious outbreaks and polypharmacy challenges in elderly populations. This evolution promises decreased emergency admissions, improved therapeutic compliance, and more cost-effective care delivery. Regulatory reform must eliminate practice limitations, enabling these accessible professionals to address population health requirements fully. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Pharmaceutical care expansion</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Precision medicine</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Digital health technology</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Advanced therapeutics</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Interprofessional collaboration</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Healthcare policy reform</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>